Screening test for preeclampsia through assessment of uteroplacental blood flow and biochemical markers of oxidative stress and endothelial dysfunction

被引:104
作者
Parra, M
Rodrigo, R
Barja, P
Bosco, C
Fernández, V
Muñoz, H
Soto-Chacón, E
机构
[1] Univ Chile, Hosp Clin, Unidad Med Fetal, Santiago, Chile
[2] Univ Chile, Fac Med, Inst Biomed Sci, Santiago 7, Chile
关键词
preeclampsia; Doppler; screening; biochemical markers;
D O I
10.1016/j.ajog.2005.02.109
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Objective: This study was undertaken to evaluate whether screening through a uterine artery (UtA) Doppler and biochemical markers of oxidative stress and endothelial dysfunction predict preeclampsia. Study design: UtA Doppler was performed at 11 to 14 and 22 to 25 weeks on 1447 asymptomatic pregnant women. Oxidative stress, endothelial dysfunction, and antiangiogenic state were assessed in women who later developed preeclampsia and normotensive controls. Results: There was a significantly increased of UtA pulsatility index (PI), plasma levels of soluble fms-like tyrosine kinase 1 (sFlt1), PAI-1/PAI-2 ratio, and F-2 isoprostane in women who subsequently developed preeclampsia compared with control pregnancies. Multivariate logistic regression showed that increased UtA PI performed at 23 weeks was the best predictor for preeclampsia. Conclusion: This study demonstrates early changes in markers of impaired placentation, antiangiogenic state, oxidative stress, and endothelial dysfunction suggesting that these derangements may play a role in the pathogenesis of preeclampsia. Our data point to UtA as the best test to predict preeclampsia at 23 weeks of gestation. (C) 2005 Mosby, Inc. All rights reserved.
引用
收藏
页码:1486 / 1491
页数:6
相关论文
共 23 条
[11]   Circulating angiogenic factors and the risk of preeclampsia [J].
Levine, RJ ;
Maynard, SE ;
Qian, C ;
Lim, KH ;
England, LJ ;
Yu, KF ;
Schisterman, EF ;
Thadhani, R ;
Sachs, BP ;
Epstein, FH ;
Sibai, BM ;
Sukhatme, VP ;
Karumanchi, SA .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (07) :672-683
[12]   Screening for pre-eclampsia and fetal growth restriction by uterine artery Doppler at 11-14 weeks of gestation [J].
Martin, AM ;
Bindra, R ;
Curcio, P ;
Cicero, S ;
Nicolaides, KH .
ULTRASOUND IN OBSTETRICS & GYNECOLOGY, 2001, 18 (06) :583-586
[13]   Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfimction, hypertension, and proteinuria in preeclampsia [J].
Maynard, SE ;
Min, JY ;
Merchan, J ;
Lim, KH ;
Li, JY ;
Mondal, S ;
Libermann, TA ;
Morgan, LP ;
Sellke, FW ;
Stillman, IE ;
Epstein, FH ;
Sukhatme, VP ;
Karumanchi, SA .
JOURNAL OF CLINICAL INVESTIGATION, 2003, 111 (05) :649-658
[14]  
Myatt L, 2000, J Matern Fetal Med, V9, P79
[15]   Multicenter screening for pre-eclampsia and fetal growth restriction by transvaginal uterine artery Doppler at 23 weeks of gestation [J].
Papageorghiou, AT ;
Yu, CKH ;
Bindra, R ;
Pandis, G ;
Nicolaides, KH .
ULTRASOUND IN OBSTETRICS & GYNECOLOGY, 2001, 18 (05) :441-449
[16]   ENZYME IMMUNOASSAYS OF EICOSANDOIDS USING ACETYLCHOLINE ESTERASE AS LABEL - AN ALTERNATIVE TO RADIOIMMUNOASSAY [J].
PRADELLES, P ;
GRASSI, J ;
MACLOUF, J .
ANALYTICAL CHEMISTRY, 1985, 57 (07) :1170-1173
[17]   Pre-eclampsia, the placenta and the maternal systemic inflammatory response - A review [J].
Redman, CWG ;
Sargent, IL .
PLACENTA, 2003, 24 :S21-S27
[18]   PLASMINOGEN-ACTIVATOR INHIBITORS (PAI-1 AND PAI-2) IN NORMAL PREGNANCIES, PREECLAMPSIA AND HYDATIDIFORM MOLE [J].
REITH, A ;
BOOTH, NA ;
MOORE, NR ;
CRUICKSHANK, DJ ;
BENNETT, B .
BRITISH JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 1993, 100 (04) :370-374
[19]  
REZNICK AZ, 1994, METHOD ENZYMOL, V233, P357
[20]   Recent insights into the pathogenesis of pre-eclampsia [J].
Roberts, JM ;
Lain, KY .
PLACENTA, 2002, 23 (05) :359-372